In contrast, an SNP in the promoter region of IL-6 (174G > C), enhancing IL-6 production in response to inflammatory stimuli, increases the risk of Alzheimer’s disease, non-insulin-dependent diabetes mellitus, and juvenile chronic arthritis [18,19,20]. Here, IL6 is linked to early-onset autosomal dominant Alzheimer disease.